![Edward D. Wirth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward D. Wirth
No open positions remaining
Profile
Edward D.
Wirth worked as the Chief Medical Officer at Asterias Biotherapeutics, Inc. from 2013 to 2019.
Prior to that, he was the Chief Science Officer at InVivo Therapeutics Corp.
in 2012, the Chief Medical Officer at Lineage Cell Therapeutics, Inc., and the Medical Director-Regenerative Medicine Division at Geron Corp.
from 2004 to 2011.
Wirth earned two doctorate degrees from the University of Florida in 1992 and 1994.
Former positions of Edward D. Wirth
| Companies | Position | End |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/03/2019 |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Chief Tech/Sci/R&D Officer | 01/09/2012 |
| GERON CORPORATION | Corporate Officer/Principal | 01/10/2011 |
| LINEAGE CELL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Edward D. Wirth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Edward D. Wirth
